599 related articles for article (PubMed ID: 28606739)
1. Covalent nano delivery systems for selective imaging and treatment of brain tumors.
Ljubimova JY; Sun T; Mashouf L; Ljubimov AV; Israel LL; Ljubimov VA; Falahatian V; Holler E
Adv Drug Deliv Rev; 2017 Apr; 113():177-200. PubMed ID: 28606739
[TBL] [Abstract][Full Text] [Related]
2. Targeting Brain Tumors with Nanomedicines: Overcoming Blood Brain Barrier Challenges.
Khaitan D; Reddy PL; Ningaraj N
Curr Clin Pharmacol; 2018; 13(2):110-119. PubMed ID: 29651960
[TBL] [Abstract][Full Text] [Related]
3. Drug delivery and targeting to brain tumors: considerations for crossing the blood-brain barrier.
Omidi Y; Kianinejad N; Kwon Y; Omidian H
Expert Rev Clin Pharmacol; 2021 Mar; 14(3):357-381. PubMed ID: 33554678
[No Abstract] [Full Text] [Related]
4. Emerging blood-brain-barrier-crossing nanotechnology for brain cancer theranostics.
Tang W; Fan W; Lau J; Deng L; Shen Z; Chen X
Chem Soc Rev; 2019 Jun; 48(11):2967-3014. PubMed ID: 31089607
[TBL] [Abstract][Full Text] [Related]
5. Drug delivery systems for brain tumor therapy.
Rautioa J; Chikhale PJ
Curr Pharm Des; 2004; 10(12):1341-53. PubMed ID: 15134485
[TBL] [Abstract][Full Text] [Related]
6. Increased Nanoparticle Delivery to Brain Tumors by Autocatalytic Priming for Improved Treatment and Imaging.
Han L; Kong DK; Zheng MQ; Murikinati S; Ma C; Yuan P; Li L; Tian D; Cai Q; Ye C; Holden D; Park JH; Gao X; Thomas JL; Grutzendler J; Carson RE; Huang Y; Piepmeier JM; Zhou J
ACS Nano; 2016 Apr; 10(4):4209-18. PubMed ID: 26967254
[TBL] [Abstract][Full Text] [Related]
7. Noninvasive nanoparticle strategies for brain tumor targeting.
Sun C; Ding Y; Zhou L; Shi D; Sun L; Webster TJ; Shen Y
Nanomedicine; 2017 Nov; 13(8):2605-2621. PubMed ID: 28756093
[TBL] [Abstract][Full Text] [Related]
8. Patented nanomedicines for the treatment of brain tumors.
Caruso G; Raudino G; Caffo M
Pharm Pat Anal; 2013 Nov; 2(6):745-54. PubMed ID: 24237240
[TBL] [Abstract][Full Text] [Related]
9. Improving drug delivery to primary and metastatic brain tumors: strategies to overcome the blood-brain barrier.
Parrish KE; Sarkaria JN; Elmquist WF
Clin Pharmacol Ther; 2015 Apr; 97(4):336-46. PubMed ID: 25669487
[TBL] [Abstract][Full Text] [Related]
10. BBB-targeting, protein-based nanomedicines for drug and nucleic acid delivery to the CNS.
Peluffo H; Unzueta U; Negro-Demontel ML; Xu Z; Váquez E; Ferrer-Miralles N; Villaverde A
Biotechnol Adv; 2015; 33(2):277-87. PubMed ID: 25698504
[TBL] [Abstract][Full Text] [Related]
11. Targeting specific cells in the brain with nanomedicines for CNS therapies.
Zhang F; Lin YA; Kannan S; Kannan RM
J Control Release; 2016 Oct; 240():212-226. PubMed ID: 26686078
[TBL] [Abstract][Full Text] [Related]
12. Recent advances in brain tumor-targeted nano-drug delivery systems.
Liu Y; Lu W
Expert Opin Drug Deliv; 2012 Jun; 9(6):671-86. PubMed ID: 22607535
[TBL] [Abstract][Full Text] [Related]
13. The blood-brain barrier: its influence in the treatment of brain tumors metastases.
Fortin D
Curr Cancer Drug Targets; 2012 Mar; 12(3):247-59. PubMed ID: 22229251
[TBL] [Abstract][Full Text] [Related]
14. Advances in Targeted Drug Delivery Approaches for the Central Nervous System Tumors: The Inspiration of Nanobiotechnology.
Meng J; Agrahari V; Youm I
J Neuroimmune Pharmacol; 2017 Mar; 12(1):84-98. PubMed ID: 27449494
[TBL] [Abstract][Full Text] [Related]
15. Chemotherapy Delivery Strategies to the Central Nervous System: neither Optional nor Superfluous.
Drapeau A; Fortin D
Curr Cancer Drug Targets; 2015; 15(9):752-68. PubMed ID: 26077730
[TBL] [Abstract][Full Text] [Related]
16. Nanomedicine as a non-invasive strategy for drug delivery across the blood brain barrier.
Tam VH; Sosa C; Liu R; Yao N; Priestley RD
Int J Pharm; 2016 Dec; 515(1-2):331-342. PubMed ID: 27769885
[TBL] [Abstract][Full Text] [Related]
17. Delivery across the blood-brain barrier: nanomedicine for glioblastoma multiforme.
Jena L; McErlean E; McCarthy H
Drug Deliv Transl Res; 2020 Apr; 10(2):304-318. PubMed ID: 31728942
[TBL] [Abstract][Full Text] [Related]
18. Promising approaches to circumvent the blood-brain barrier: progress, pitfalls and clinical prospects in brain cancer.
Papademetriou IT; Porter T
Ther Deliv; 2015; 6(8):989-1016. PubMed ID: 26488496
[TBL] [Abstract][Full Text] [Related]
19. Perspectives on Dual Targeting Delivery Systems for Brain Tumors.
Gao H
J Neuroimmune Pharmacol; 2017 Mar; 12(1):6-16. PubMed ID: 27270720
[TBL] [Abstract][Full Text] [Related]
20. The blood-brain barrier and blood-tumour barrier in brain tumours and metastases.
Arvanitis CD; Ferraro GB; Jain RK
Nat Rev Cancer; 2020 Jan; 20(1):26-41. PubMed ID: 31601988
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
